C WorldWide Group’s Accelerate Diagnostics AXDX Stock Holding History

C WorldWide Group’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-52,468	Closed	-$3.98M	–	95
2020 Q4	$3.98M	Hold	52,468	–	–	0.04%	70
2020 Q3	$5.59M	Hold	52,468	–	–	0.06%	56
2020 Q2	$7.95M	Hold	52,468	–	–	0.09%	54
2020 Q1	$4.37M	Hold	52,468	–	–	0.06%	58
2019 Q4	$8.87M	Hold	52,468	–	–	0.11%	53
2019 Q3	$9.74M	Hold	52,468	–	–	0.12%	50
2019 Q2	$12M	Buy	52,468 +41,000	+358%	+$8.02M	0.15%	49
2019 Q1	$2.41M	Hold	11,468	–	–	0.03%	86
2018 Q4	$1.32M	Sell	11,468 -4,069	-26%	-$603K	0.02%	95
2018 Q3	$3.57M	Sell	15,537 -2,894	-16%	-$640K	0.05%	77
2018 Q2	$4.11M	Buy	+18,431	New	+$4.12M	0.06%	73

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

C WorldWide Group's AXDX Position: Q1 2021 in Review

C WorldWide Group sold out of Accelerate Diagnostics (AXDX) in Q1 2021, closing a stake of 52,468 shares — an estimated $3.98M sold.

C WorldWide Group first reported a position in AXDX in Q2 2018 and held it in 11 quarters. The position peaked at $12M in Q2 2019. 99 funds tracked by Wall St. Rank hold AXDX as of Q1 2021.

C WorldWide Group reported no remaining Accelerate Diagnostics position as of Q1 2021 after selling out during the quarter.
C WorldWide Group sold 52,468 Accelerate Diagnostics shares in Q1 2021, an estimated $3.98M.
C WorldWide Group first reported a position in Accelerate Diagnostics in Q2 2018 and held it in 11 quarters.
C WorldWide Group's Accelerate Diagnostics position peaked at $12M in Q2 2019.
99 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2021.

Based on C WorldWide Group's 13F filing for Q1 2021, filed 4 May 2021.